China Construction Bank International is a Hong Kong-based investment banking and financial-services arm associated with China Construction Bank, relevant to founders as a strategic financial-institution capital provider. Its investment activity includes UK private companies, with sector exposure to finance, life sciences and biotechnology, including molecular-analysis and genome-sequencing technology.